Question # 34

A 62-year-old woman completed adjuvant doxorubicin/cyclophosphamide for stage II ER+/HER2- breast cancer 12 months ago. She has hypertension and obesity. Which survivorship follow-up is MOST appropriate to address late effects?

Options:

A.

Annual PET/CT to screen for recurrence

B.

Echocardiogram now and periodic surveillance based on risk; reinforce cardiovascular risk reduction and exercise prescription

C.

Tumor markers (CA 15-3) every 3 months indefinitely

D.

No further surveillance needed after one year

Viewing question 34 out of 72 questions
Industry research shows that students who utilize AOCNP practice tests are significantly more likely to pass exam.


Our free AOCNP practice questions act as a diagnostic tool to give you a clear snapshot of your Advanced Oncology Certified Nurse Practitioner readiness. Discover which topics are your strengths and, more importantly, which critical topics require your immediate attention.